Viewing Study NCT02858661


Ignite Creation Date: 2025-12-24 @ 12:00 PM
Ignite Modification Date: 2025-12-30 @ 11:07 PM
Study NCT ID: NCT02858661
Status: COMPLETED
Last Update Posted: 2023-04-21
First Post: 2016-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Improving the Diagnosis of Meningitis in Emergency Rooms
Sponsor: Assistance Publique Hopitaux De Marseille
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A point-of-care laboratory (POC) was set at North Hospital, Marseille, France for the diagnosis in less than two hours of meningitis caused by known pathogens, close to the reception of Emergency service. In this instance 30% of patients have no etiological diagnosis after the POC diarrhoea tests . This lab has discovered over 200 new species of bacteria in humans, including vector bacteria and opened the field of large Deoxyribonucleic Acid (DNA ) viruses. Also, the laboratory of emerging viruses discovered many Ribonucleic Acid (RNA) viruses transmitted by arthropods. Based on this collection of new pathogens described in POC laboratory, this study proposes to expand the etiological diagnosis strategy of meningitis after POC test.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: